[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2014/78813,2014,A1Locationinpatent:Page/Pagecolumn131
[1]CurrentPatentAssignee:INVENTIVASA-US2017/66717,2017,A1Locationinpatent:Paragraph2442-2445
105679-22-9
1350738-87-2
154264-95-6
58960-13-7
866089-28-3
1245708-33-1
1207176-24-6 | tert-Butyl 4-(bromomethyl)-4-fluoropiperidine-1-carboxylate | AA00HFMK | MFCD11973737
1211592-94-7 | Ethyl 3-((1-(tert-butoxycarbonyl)piperidin-4-yl)methyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate | AA00HFWY | MFCD12755391
1217776-08-3 | Boc-4,5-dehydro-d-leu-oh dcha | AA00HGBZ | MFCD04112665
1227597-40-1 | 2,4-Dichloro-5-methoxypyridine | AA00HGUN | MFCD16610792
123484-90-2 | (2S)-2-(4-Bromophenyl)-2-hydroxyacetic acid | AA00HH8I | MFCD00798440
1246090-95-8 | (E)-Methyl 3-(6-cyano-5-fluoropyridin-3-yl)-acrylate | AA00HHNJ | MFCD17171330
1251009-06-9 | (4As*,8as*)-tert-butyl-hexahydro-2h-pyrido[4,3-b][1,4]oxazine-6(7h)-carboxylate | AA00HHY3 | MFCD14581085
1257069-38-7 | 3-Amino-5-fluoropyridin-2-ol | AA00HICV | MFCD19216201
1261297-63-5 | tert-Butyl 6-fluoro-1,4-diazepane-1-carboxylate | AA00HITG | MFCD18791252
1262860-62-7 | Methyl 5-chloro-3-methylpyrazine-2-carboxylate | AA00HRD2 | MFCD22548380